Does exist relationship between plasma adiponectin concentration and selected parameters of metabolic syndrome?;Czy istnieje zależność miȩdzy stȩżeniem adiponektyny a wybranymi elementami zespołu metabolicznego?

Polski Merkuriusz Lekarski

Volumn 21, Issue 122, 2006, Pages 170-173

  Miczke, Anna ^a,b   Szulińska, Monika ^a   Bogdański, Paweł ^a   Pupek Musialik, Danuta ^a   Manitius, Jacek ^c   Nartowicz, Edmund ^c   Litwin, Mieczysław ^c  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Katedra i Klinika Chorob Wewnetrznych   (Poland)

^c AM ^*

Author keywords

Adiponectin; Insulin sensitivity; Metabolic syndrome

Indexed keywords

ADIPONECTIN; HIGH DENSITY LIPOPROTEIN; LIPID; BIOLOGICAL MARKER;

ADIPOSE TISSUE; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HYPERTENSION; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; BLOOD; COMORBIDITY; FEMALE; INSULIN RESISTANCE; MALE; PHYSIOLOGY; SECRETION;

ADIPONECTIN; ADIPOSE TISSUE; ANTHROPOMETRY; BIOLOGICAL MARKERS; BODY MASS INDEX; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; OBESITY;

EID: 33748493789     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Arita Y., Kihara S., Ouchi N. i wsp.: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun., 1999, 257, 79-83.
2. Barger P.M., Browning A.C., Garner i wsp.: p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor alpha: a potential role in the cardiac metabolic stress response. J. Biol. Chem., 2001, 276-281.
3. Delporte M.L., Lambert M.J., Hermans M.P. i wsp. Hyperadiponectinemia in anorexia nervosa. Diabetologia, 2002, 45(1), A223-A224.
4. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panels on Detections, Evaluation and Treatment of High Blood Cholesterol in Adults (ATP III). JAMA, 2001, 285, 2480-2497.
5. Fruebis J., Tsao T.S., Javorschi S i wsp.: Proteolylic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci., USA, 2001, 98-104.
6. Hardie D.G., Scott J.W., Pan D.A. i wsp. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett., 2003, 546, 1-6.
7. Hotta K., Funahashi T., Arita Y. i wsp.: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol., 2000, 20, 1595-1599.
8. Imagawa A., Funahashi T., Nakamura T. i wsp.: Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes. Diabetes Care 2002, 25, 1665-1666.
9. Isomaa B., Almgren P., Toumi T. i wsp.: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 2001, 4, 683-689.
10. Iwashima Y., Katsuya T., Ishikawa K. i wsp.: Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension, 2004, 43, 1-6.
11. Kharroubi I., Rasschaert J., Eizirik D.L.: Expression of adiponectin receptors in pancreatic beta cells. Biochem. Biophys. Res. Commun., 2003, 312, 4-8.
12. Lee C., Olson P., Evans R.M.: Minireview: Lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology, 2003, 144-153.
13. Maeda K., Okubo K., Shimomura I. i wsp.: cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1. Biochem. Biophys. Res. Commun. 1996, 221, 286-289.
14. Scherer P.E., Williams S., Fogliano M. i wsp.: A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem., 1995, 270, 26746-26749.
15. Takahashi M., Arita Y., Yamagata K. i wsp.: Genomic structure and mutations in adipose-specific gene, adiponectin. Int. J. Obes. Relat. Metab. Disord., 2000, 24(7), 861-868.
16. Weyer C., Funahashi T., Tanaka S. i wsp.: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab., 2001, 86, 1930-1935.
17. Yamamoto Y., Hirose H., Saito I. i wsp.: Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clinical Sciences, 2002, 103, 137-142.
18. Yamauchi T., Kamon J., Ito Y. i wsp.: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature, 2003, 423, 6941-6948.
19. Yamauchi T., Kamon J., Waki J. i wsp.: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine, 2001, 7, 941-946.
20. Zoccali C., Mallamaci F., Tripepi G. i wsp.: Adiponectin, metabolic risk factors, and cardiovascular events among patients with end - stage renal disease. Journal of the American Society of Nephrology, 2002, 13, 134-141.